Skip to content
10-Q

Quarterly Report

Universal Biosensors, Inc.

0001437749-23-021090

← back to feed
Filed
Jul 31, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Jul 28, 2023 212.37M sh
Cash And Equivalents Q2 2023 · Jun 30, 2023 16.32M
Cash And Equivalents Q2 2023 · Dec 31, 2022 25.98M
Current Liabilities Q2 2023 · Jun 30, 2023 7.46M
Current Liabilities Q2 2023 · Dec 31, 2022 13.09M
Total Liabilities Q2 2023 · Jun 30, 2023 14.25M
Total Liabilities Q2 2023 · Dec 31, 2022 20.05M
Current Assets Q2 2023 · Jun 30, 2023 28.55M
Current Assets Q2 2023 · Dec 31, 2022 36.67M
Total Assets Q2 2023 · Jun 30, 2023 37.99M
Total Assets Q2 2023 · Dec 31, 2022 46.15M
Capex Q2 2023 · Jun 30, 2022 406.13K
Operating Cash Flow Q2 2023 · Jun 30, 2022 −9.66M
Stockholders Equity Q2 2023 · Jun 30, 2022 43.57M
Stockholders Equity Q2 2023 · Mar 31, 2022 23.19M
Stockholders Equity Q2 2023 · Dec 31, 2021 27.61M
Eps Basic Q2 2023 · Jun 30, 2022 −0.02
Eps Basic Q2 2023 · Jun 30, 2022 −0.05
Sga Expense Q2 2023 · Jun 30, 2022 2.76M
Sga Expense Q2 2023 · Jun 30, 2022 4.68M
Rd Expense Q2 2023 · Jun 30, 2022 2.77M
Rd Expense Q2 2023 · Jun 30, 2022 6.33M
Net Income Q2 2023 · Jun 30, 2022 −4.65M
Net Income Q2 2023 · Jun 30, 2022 −9.18M
Operating Income Q2 2023 · Jun 30, 2022 −5.57M
Operating Income Q2 2023 · Jun 30, 2022 −11.19M
Gross Profit Q2 2023 · Jun 30, 2022 825.58K
Gross Profit Q2 2023 · Jun 30, 2022 1.24M
Cost Of Revenue Q2 2023 · Jun 30, 2022 534.99K
Cost Of Revenue Q2 2023 · Jun 30, 2022 1.84M